Orthobiologics

The larger products offer better support in surgeries requiring coverage of larger areas of tissue damage (e.g., orthopedic trauma procedures)....

ViviGen MIS viable bone matrix, previously used in MIS spine procedures, is now available for use in trauma procedures....

The product is a cancellous bone graft solution using Induce Biologics’ proprietary process, which unlocks the growth factors naturally found...

Attrax Putty bone graft substitute is now on-label for use with cervical Modulus interbody implants....

BIOINCYTE is a next-generation autologous fibrin and platelet system that converts traditional PRP to platelet rich fibrin matrix formulations....

DiscGenics announced positive two-year clinical data from its study of discogenic progenitor cell therapy in the treatment of degenerative disc...

OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgery....

Orthofix Medical announced results from a prospective, multicenter clinical study evaluating the safety and efficacy of the Trinity Elite™ cellular...

The data supports development of autologous and allogeneic therapeutics for bone defects and orthopedic conditions....

XCELL PC is designed to offer easier use and reduced processing time compared to earlier generation blood and plasma filters...